Untargeted antifungal treatment with any antifungal drug (systemic or nonabsorbable) vs Placebo, no treatment, or another active antifungal intervention
Proven invasive fungal infection · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… may leads to lower proven invasive fungal infection compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
- Antifungal agents for preventing fungal infections in non‐neutropenic critically ill patients 2016 · Cochrane Headline outcomes onlyRR 0.57 [0.39, 0.83]17 studies · 2024 participantsLow